Literature DB >> 668189

Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

M B Pepys, A C Dash, R E Markham, H C Thomas, B D Williams, A Petrie.   

Abstract

The serum concentration of protein SAP (amyloid P component) has been measured for the first time in a substantial series of normal individuals and patients with various diseases, and the results contrasted with the levels of the related protein C-reactive protein (CRP). The mean +/- s.d. concentration of protein SAP was 43 +/- 14 microgram/ml in seventy-six normal men, 33 +/- 10 microgram/ml in eighty-six normal women and 4 +/- 2 microgram/ml in thirty-six normal cord sera. Unlike CRP, whick is a major acute phase reactant, protein SAP was only slightly elevated in inflammatory and neoplastic diseases in which CRP was greatly increased. The level of protein SAP was significantly depressed in patients with hepatic disease, suggesting that its measurement might be of value in their management.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668189      PMCID: PMC1541304     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Immunoassay of P-component in amyloidotic sera.

Authors:  E S Cathcart; F A Wollheim; A S Cohen
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

2.  Amino acid sequence similarities between amyloid P component C1t and CRP.

Authors:  Y Levo; B Frangione; E C Franklin
Journal:  Nature       Date:  1977-07-07       Impact factor: 49.962

3.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  [Human serum proteins with affinity for carboxymethyl cellulose. 3. Physico-chemical and immunological characterization of a metal-binding 9.5S- 1-glycoprotein (CM-protein 3)].

Authors:  H Haupt; N Heimburger; T Kranz; S Baudner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-12

5.  Clinical observation on the origin of C-reactive protein in blood.

Authors:  T Uete; K Ogi; S Fukazawa; Y Takeuchi
Journal:  Clin Biochem       Date:  1971-04       Impact factor: 3.281

6.  Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein.

Authors:  M B Pepys; A C Dash
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

7.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

8.  Effects of C-reactive protein on platelet function. I. Inhibition of platelet aggregation and release reactions.

Authors:  B A Fiedel; H Gewurz
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

9.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

10.  The liver as the site of C-reactive protein formation.

Authors:  J Hurlimann; G J Thorbecke; G M Hochwald
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

View more
  64 in total

1.  Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.

Authors:  C J de Haas; E M van Leeuwen; T van Bommel; J Verhoef; K P van Kessel; J A van Strijp
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Authors:  Monica H Kristiansson; Vadiraja B Bhat; I Ramesh Babu; John S Wishnok; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2007-03-28       Impact factor: 4.466

4.  Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.

Authors:  Diane D Shao; Rahul Suresh; Varsha Vakil; Richard H Gomer; Darrell Pilling
Journal:  J Leukoc Biol       Date:  2008-03-10       Impact factor: 4.962

5.  Pentraxins and IgA share a binding hot-spot on FcαRI.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Lorraine Marnell; Terry W Du Clos; Peter Sun
Journal:  Protein Sci       Date:  2014-01-28       Impact factor: 6.725

6.  Systemic lupus erythematosus in childhood.

Authors:  F Caeiro; F M Michielson; R Bernstein; G R Hughes; B M Ansell
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

7.  Metabolism of human beta 1H: studies in man and experimental animals.

Authors:  J A Charlesworth; D M Scott; B A Pussell; D K Peters
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

8.  Studies of the structure and binding properties of hamster female protein.

Authors:  G A Tennent; M L Baltz; G D Osborn; P J Butler; G E Noble; P N Hawkins; M B Pepys
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

9.  Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains.

Authors:  M Kimura; H Arai; T Takahashi; N Iwamoto
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

Authors:  Julian D Gillmore; Winston L Hutchinson; Jeff Herbert; Alison Bybee; Daniel A Mitchell; Robert P Hasserjian; Ken-Ichi Yamamura; Misao Suzuki; Caroline A Sabin; Mark B Pepys
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.